Literature DB >> 23376117

Intrapallidal administration of 6-hydroxydopamine mimics in large part the electrophysiological and behavioral consequences of major dopamine depletion in the rat.

P M Abedi1, C Delaville, P De Deurwaerdère, W Benjelloun, A Benazzouz.   

Abstract

In addition to GABA and glutamate innervations, the globus pallidus (GP) receives dopamine afferents from the pars compacta of the substantia nigra (SNc), and in turn, sends inhibitory GABAergic efferents to the subthalamic nucleus (STN) and the pars reticulata of the substantia nigra (SNr). Nevertheless, the role of dopamine in the modulation of these pallido-subthalamic and pallido-nigral projections is not known. The present study aimed to investigate the effects of intrapallidal injection of 6-hydroxydopamine (6-OHDA) on the electrical activity of STN and SNr neurons using in vivo extracellular single unit recordings in the rat and on motor behaviors, using the "open field" actimeter and the stepping test. We show that intrapallidal injection of 6-OHDA significantly decreased locomotor activity and contralateral paw use. Electrophysiological recordings show that 6-OHDA injection into GP significantly increased the number of bursty cells in the STN without changing the firing rate, while in the SNr neuronal firing rate decreased and the proportion of irregular cells increased. Our data provide evidence that intrapallidal injection of 6-OHDA resulted in motor deficits paralleled by changes in the firing activity of STN and SNr neurons, which mimic in large part those obtained after major dopamine depletion in the classical rat model of Parkinson's disease. They support the assumption that in addition to its action in the striatum, dopamine mediates its regulatory function at various levels of the basal ganglia circuitry, including the GP.
Copyright © 2013 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23376117     DOI: 10.1016/j.neuroscience.2013.01.043

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  15 in total

1.  Inhibiting subthalamic D5 receptor constitutive activity alleviates abnormal electrical activity and reverses motor impairment in a rat model of Parkinson's disease.

Authors:  Jonathan Chetrit; Anne Taupignon; Lionel Froux; Stephanie Morin; Rabia Bouali-Benazzouz; Frédéric Naudet; Nabila Kadiri; Christian E Gross; Bernard Bioulac; Abdelhamid Benazzouz
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

2.  HCN channels modulate the activity of the subthalamic nucleus in vivo.

Authors:  Wen-Shuai Deng; Yun-Xia Jiang; Xiao-Hua Han; Yan Xue; Hua Wang; Peng Sun; Lei Chen
Journal:  J Mol Neurosci       Date:  2014-05-21       Impact factor: 3.444

3.  Olfactory mucosa stem cells delivery via nasal route: a simple way for the treatment of Parkinson disease.

Authors:  Sara Simorgh; Rafieh Alizadeh; Ronk Shabani; Fariba Karimzadeh; Elham Seidkhani; Jamal Majidpoor; Fatemeh Moradi; Hamidreza Kasbiyan
Journal:  Neurotox Res       Date:  2021-01-12       Impact factor: 3.911

4.  Disrupted basal ganglia output during movement preparation in hemiparkinsonian mice is consistent with behavioral deficits.

Authors:  Anand Tekriwal; Mario J Lintz; John A Thompson; Gidon Felsen
Journal:  J Neurophysiol       Date:  2021-08-18       Impact factor: 2.974

5.  Npas1+ Pallidal Neurons Target Striatal Projection Neurons.

Authors:  Kelly E Glajch; Daniel A Kelver; Daniel J Hegeman; Qiaoling Cui; Harry S Xenias; Elizabeth C Augustine; Vivian M Hernández; Neha Verma; Tina Y Huang; Minmin Luo; Nicholas J Justice; C Savio Chan
Journal:  J Neurosci       Date:  2016-05-18       Impact factor: 6.167

Review 6.  Review: electrophysiology of basal ganglia and cortex in models of Parkinson disease.

Authors:  Damien J Ellens; Daniel K Leventhal
Journal:  J Parkinsons Dis       Date:  2013-01-01       Impact factor: 5.568

7.  Magnetic Targeting of Human Olfactory Mucosa Stem Cells Following Intranasal Administration: a Novel Approach to Parkinson's Disease Treatment.

Authors:  Sara Simorgh; Zohreh Bagher; Mohammad Farhadi; Seyed Kamran Kamrava; Mahdi Eskandarian Boroujeni; Zeinab Namjoo; Farshid Qiyami Hour; Salah Moradi; Rafieh Alizadeh
Journal:  Mol Neurobiol       Date:  2021-04-15       Impact factor: 5.590

Review 8.  Involvement of dopamine loss in extrastriatal basal ganglia nuclei in the pathophysiology of Parkinson's disease.

Authors:  Abdelhamid Benazzouz; Omar Mamad; Pamphyle Abedi; Rabia Bouali-Benazzouz; Jonathan Chetrit
Journal:  Front Aging Neurosci       Date:  2014-05-13       Impact factor: 5.750

Review 9.  Synchrony in Parkinson's disease: importance of intrinsic properties of the external globus pallidus.

Authors:  Bettina C Schwab; Tjitske Heida; Yan Zhao; Enrico Marani; Stephan A van Gils; Richard J A van Wezel
Journal:  Front Syst Neurosci       Date:  2013-10-04

10.  Neuronal activity (c-Fos) delineating interactions of the cerebral cortex and basal ganglia.

Authors:  Mei-Hong Qiu; Michael C Chen; Zhi-Li Huang; Jun Lu
Journal:  Front Neuroanat       Date:  2014-03-26       Impact factor: 3.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.